ARIMIDEX
1MG TBL FLM 84
| SÚKL code | 0231853 |
|---|---|
| Name of the product | ARIMIDEX |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | ARIMIDEX |
| Supplement | 1MG TBL FLM 84 |
| Strenght | 1MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 84 |
| Route | Oral use |
| Language of the pack | Czech |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance | ANASTROZOLE (ANASTROZOLUM) |
| ATC group | L02BG03 |
| ATC group name | ANASTROZOL |
| Doping | Antagonisté a modulátory hormonů (nelze pro léčbu sportovců použít vůbec). Bližší informace viz http://www.antidoping.cz/. |
Marketing authorisation information
| Registration Number | 44/1296/97-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 30. 09. 2021 |
| MA Holder | AstraZeneca AB, Södertälje |
| MA Holder country | ŠVÉDSKO |
| Actual MA holder | Laboratoires Juvisé Pharmaceuticals, Villeurbanne |
| Actual MA holder country | FRANCIE |
cz